The novel treatment of this peptide represents a major development in the care of type 2 diabetes. Unlike existing drugs, tirzepatide affects dual pathways – GLP-1 and the GIP hormone – resulting in enhanced sugar https://tirzepatidepeptide618575.yomoblog.com/49468630/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment